NFinanSe raises $10.9 million
nFinanSe Inc. raised $10.9 million in the sale of preferred stock and warrants convertible to common stock.
Arginetix Inc., a Baltimore-based developer of small molecule inhibitors of arginase, has raised $2.3 million in first-round funding.